No Data
Edwards Lifesciences to Report Q3 Earnings: What's in the Cards?
Express News | Edwards Lifesciences Corp : Mizuho Cuts Target Price to $78 From $85
Analysts Conflicted on These Healthcare Names: Allakos (ALLK), Edwards Lifesciences (EW) and NewAmsterdam Pharma Company (NAMS)
Great Week for Edwards Lifesciences Corporation (NYSE:EW) Institutional Investors After Losing 2.4% Over the Previous Year
Morgan Stanley Downgrades Edwards Lifesciences(EW.US) to Hold Rating, Cuts Target Price to $70
Edwards Lifesciences Resumed With an Equal Weight at Morgan Stanley
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}